Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Fixed-dose single tablet antidiabetic combinations.

Bailey CJ, Day C.

Diabetes Obes Metab. 2009 Jun;11(6):527-33. doi: 10.1111/j.1463-1326.2008.00993.x. Epub 2009 Jan 19. Review.

PMID:
19175373
[PubMed - indexed for MEDLINE]
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
[PubMed - indexed for MEDLINE]
4.

The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.

Howlett H, Porte F, Allavoine T, Kuhn T, Nicholson G.

Curr Med Res Opin. 2003;19(3):218-25.

PMID:
12803736
[PubMed - indexed for MEDLINE]
5.

[Antidiabetic fixed-dose combination tablet for the management of type 2 diabetes].

Sakane N.

Nihon Rinsho. 2012 Jan;70(1):165-70. Review. Japanese.

PMID:
22413513
[PubMed - indexed for MEDLINE]
6.

Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects.

He YL, Paladini S, Sabia H, Campestrini J, Zhang Y, Leon S, Ligueros-Saylan M, Jarugula V.

Int J Clin Pharmacol Ther. 2008 May;46(5):259-67.

PMID:
18538112
[PubMed - indexed for MEDLINE]
7.

Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments.

Mooradian AD.

Treat Endocrinol. 2004;3(5):279-87. Review.

PMID:
15330676
[PubMed - indexed for MEDLINE]
8.

Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.

Dailey GE.

Expert Opin Pharmacother. 2003 Aug;4(8):1417-30. Review.

PMID:
12877648
[PubMed - indexed for MEDLINE]
9.

Oral antidiabetic drugs: bioavailability assessment of fixed-dose combination tablets of pioglitazone and metformin. Effect of body weight, gender, and race on systemic exposures of each drug.

Karim A, Slater M, Bradford D, Schwartz L, Zhao Z, Cao C, Laurent A.

J Clin Pharmacol. 2007 Jan;47(1):37-47.

PMID:
17192500
[PubMed - indexed for MEDLINE]
11.

Treatment of type 2 diabetes mellitus with orally administered agents: advances in combination therapy.

Bain SC.

Endocr Pract. 2009 Nov-Dec;15(7):750-62. doi: 10.4158/EP08317.RAR. Review.

PMID:
19625236
[PubMed - indexed for MEDLINE]
12.
13.

Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care.

Schernthaner G.

Diabet Med. 2010 Jul;27(7):739-43. doi: 10.1111/j.1464-5491.2010.03000.x. Review.

PMID:
20636953
[PubMed - indexed for MEDLINE]
14.

Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.

Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A.

Clin Ther. 2004 Dec;26(12):2066-75.

PMID:
15823770
[PubMed - indexed for MEDLINE]
15.

Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.

Bailey CJ, Day C.

Int J Clin Pract. 2004 Sep;58(9):867-76. Review.

PMID:
15529521
[PubMed - indexed for MEDLINE]
16.

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.

Blonde L, Wogen J, Kreilick C, Seymour AA.

Diabetes Obes Metab. 2003 Nov;5(6):424-31.

PMID:
14617228
[PubMed - indexed for MEDLINE]
17.

Pioglitazone/metformin.

Deeks ED, Scott LJ.

Drugs. 2006;66(14):1863-77; discussion 1878-80.

PMID:
17040116
[PubMed - indexed for MEDLINE]
18.

Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):187-93.

PMID:
16285076
[PubMed - indexed for MEDLINE]
19.

Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.

Davidson JA, Scheen AJ, Howlett HC.

Drug Saf. 2004;27(15):1205-16. Review.

PMID:
15588116
[PubMed - indexed for MEDLINE]
20.

Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.

Marre M, Howlett H, Lehert P, Allavoine T.

Diabet Med. 2002 Aug;19(8):673-80.

PMID:
12147149
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk